Dan R. Burns
Chief Executive Officer at InfaCare Pharmaceutical Corp.
Profile
Dan R.
Burns is currently the President, Chief Executive Officer & Director at InfaCare Pharmaceutical Corp.
He previously held positions as the Chief Executive Officer at ProScript, Inc. from 1998 to 1999, Chief Executive Officer at HealthTalk, Inc. from 2000 to 2002, and Vice President-Business Development at MannKind Corp.
He also served as the President & Chief Operating Officer at Trophix Pharmaceuticals, Inc. from 1997 to 1998.
Mr. Burns has a background in business and holds an undergraduate degree from McMaster University and Mohawk College.
Dan R. Burns active positions
| Companies | Position | Start |
|---|---|---|
InfaCare Pharmaceutical Corp.
 InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | Chief Executive Officer | 2007-03-31 |
Former positions of Dan R. Burns
| Companies | Position | End |
|---|---|---|
| MANNKIND CORPORATION | Corporate Officer/Principal | 2007-02-15 |
HealthTalk, Inc.
 HealthTalk, Inc. Internet Software/ServicesTechnology Services HealthTalk, Inc. provides online health information services. It offers services in the areas such as asthma, chronic lymphocytic leukemia, psoriasis, migraine, sclerosis, and rheumatoid arthritis. The company was founded by Greg Harris in 2007 and is headquartered in Seattle, WA. | Chief Executive Officer | 2001-12-31 |
ProScript, Inc.
 ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | Chief Executive Officer | 1998-12-31 |
Trophix Pharmaceuticals, Inc.
 Trophix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of NPS Allelix Corp., Trophix Pharmaceuticals, Inc. develops pharmaceutical products. The company is based in South Plainfield, NJ. The company was founded by Jeffrey F. McKelvy. Trophix Pharmaceuticals was acquired by Allelix Biopharmaceuticals, Inc. on July 30, 1997 for $27 million. | President | 1997-12-31 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Training of Dan R. Burns
| McMaster University | Undergraduate Degree |
| Mohawk College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MANNKIND CORPORATION | Health Technology |
| Private companies | 4 |
|---|---|
InfaCare Pharmaceutical Corp.
InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | Health Technology |
Trophix Pharmaceuticals, Inc.
Trophix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of NPS Allelix Corp., Trophix Pharmaceuticals, Inc. develops pharmaceutical products. The company is based in South Plainfield, NJ. The company was founded by Jeffrey F. McKelvy. Trophix Pharmaceuticals was acquired by Allelix Biopharmaceuticals, Inc. on July 30, 1997 for $27 million. | Health Technology |
ProScript, Inc.
ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | Health Technology |
HealthTalk, Inc.
HealthTalk, Inc. Internet Software/ServicesTechnology Services HealthTalk, Inc. provides online health information services. It offers services in the areas such as asthma, chronic lymphocytic leukemia, psoriasis, migraine, sclerosis, and rheumatoid arthritis. The company was founded by Greg Harris in 2007 and is headquartered in Seattle, WA. | Technology Services |
- Stock Market
- Insiders
- Dan R. Burns
